相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
Tari A. King et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Histopathologic Correlation of Residual Mammographic Microcalcifications After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Beatriz E. Adrada et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Calcifications on Mammogram Do Not Correlate with Tumor Size After Neoadjuvant Chemotherapy
Anna Weiss et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy
Hyeong-Gon Moon et al.
ANNALS OF SURGERY (2013)
Analysis of Factors that Influence the Accuracy of Magnetic Resonance Imaging for Predicting Response after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Eun Sook Ko et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
Michael L. Marinovich et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Neoadjuvant Chemotherapy in the Treatment of Breast Cancer
Meredith H. Redden et al.
SURGICAL CLINICS OF NORTH AMERICA (2013)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
Valentina Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Jose Baselga et al.
LANCET (2012)
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
Michael Untch et al.
LANCET ONCOLOGY (2012)
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy-Results from ACRIN 6657/I-SPY TRIAL
Nola M. Hylton et al.
RADIOLOGY (2012)
MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?
Kandace P. McGuire et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Accuracy of Clinical Examination, Digital Mammogram, Ultrasound, and MRI in Determining Postneoadjuvant Pathologic Tumor Response in Operable Breast Cancer Patients
Randal Croshaw et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Vascular characterisation of triple negative breast carcinomas using dynamic MRI
Sonia P. Li et al.
EUROPEAN RADIOLOGY (2011)
MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes
Hiroshi Nakahara et al.
BREAST CANCER (2011)
Role of Breast MR Imaging in Neoadjuvant Chemotherapy
H. Carisa Le-Petross et al.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2010)
Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment
H. -G. Moon et al.
ANNALS OF ONCOLOGY (2009)
Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland
A. Spitale et al.
ANNALS OF ONCOLOGY (2009)
Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer
Lindsay W. Turnbull
NMR IN BIOMEDICINE (2009)
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Alfonso Sanchez-Munoz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy
Jacqueline S. Jeruss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference
Thomas A. Buchholz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
Yingbing Wang et al.
RADIOLOGY (2008)
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
Bhumsuk Keam et al.
BMC CANCER (2007)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Neoadjuvant chemotherapy for operable breast cancer
J. S. D. Mieog et al.
BRITISH JOURNAL OF SURGERY (2007)
Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer
Myron S. Kwong et al.
CANCER JOURNAL (2006)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy
AB Chagpar et al.
ANNALS OF SURGERY (2006)
Mammographic appearance of microcalcifications: Can they change after neoadjuvant chemotherapy?
LE Esserman et al.
BREAST JOURNAL (2006)
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer
E Yeh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Neoadjuvant chemotherapy in breast cancer
H Charfare et al.
BRITISH JOURNAL OF SURGERY (2005)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy
EL Rosen et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
JA van der Hage et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
